添加微信 添加微信
添加微信
首页: 全球医药政策

中国-WuXi AppTec Group

时间:2021-10-21 12:45:24 来源:康安医药咨询 作者:康安医药咨询

WuXi AppTec Group is a leading global pharmaceutical, medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec Group provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, and medical device testing, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi AppTec Group’s dream that “every drug can be made and every disease can be treated.” The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services, WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.

Phone: 86, (21), 5046-1111 E-mail: wuxiconcierge@wuxiapptec.com
Web: http://www.wuxiapptec.com
Add:288 Fute Zhong Road ,Waigaoqiao Free Trade Zone ,Shanghai 200131 9 Yuegong Road, Jinshan District Shanghai 201507, China

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章